Bioorganic and Medicinal Chemistry Letters p. 907 - 912 (1997)
Update date:2022-08-04
Topics:
Astles, Peter C.
Brown, Thomas J.
Cox, Paul
Halley, Frank
Lockey, Peter M.
McCarthy, Clive
McLay, Iain M.
Majid, Tahir N.
Morley, Andrew D.
Porter, Barry
Ratcliffe, Andrew J.
Walsh, Roger J.A.
A series of phenylguanidines which bind to the C5a receptor has been developed. The lead compound 1 (IC50 = 30 μM), discovered through random screening, has been modified to provide 32 (RPR121154) with submicromolar activity. This compound was
View MoreJinan Jiaquan Chemical Co.,Ltd
Contact:+86-531-62318366
Address:Room 502 of Yidonghuayuan No.601 Huaxin Road Licheng District Jinan China
Anhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
SuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Xinjiang Fufeng Biotechnologies Co., Ltd.
Contact:+86-539-7287111
Address:GANQUANPU INDUSTRIAL PARK, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT AREA (TOUTUNHE DISTRICT) OF URUMQI
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Doi:10.3184/174751912X13383107316656
(2012)Doi:10.1016/j.ejmech.2013.05.035
(2013)Doi:10.1002/ejic.201201427
(2013)Doi:10.1039/c39920001247
(1992)Doi:10.1055/s-0032-1316899
(2013)Doi:10.1021/ja972099o
(1997)
